GLOBAL HEALTH & SOCIAL MEDICINE
Dr. Velásquez's research has examined the optimal construction of regimens to treat multi-drug-resistant tuberculosis (MDR-TB) in Tomsk, Russian Federation, and evaluated the association between HIV co-infection and pyrazinamide resistance on TB outcomes in Lima, Peru. He currently works with Dr. Carole Mitnick and her group on the safety analysis of a Phase II clinical trial (HIRIF) examining the potential of high-dose rifampin to shorten standard TB therapy in Peru, and on the implementation of a Phase III clinical trial (endTB) evaluating the efficacy of new combination regimens for treatment of MDR-TB in Georgia, Kazakhstan, Kyrgyzstan, Lesotho, and Peru.
Gustavo E. Velásquez, MD, MPH is an associate physician in the Division of Infectious Diseases at Brigham and Women’s Hospital. He is an instructor in the Department of Medicine and a research associate in the Department of Global Health and Social Medicine at Harvard Medical School. Dr. Velásquez received his MD from the Northwestern University Feinberg School of Medicine and his MPH from the Harvard T.H. Chan School of Public Health in 2009. He completed his residency in Global Health Equity and Internal Medicine at Brigham and Women’s Hospital in 2013 and his fellowship in Infectious Diseases at Massachusetts General Hospital and Brigham and Women’s Hospital in 2015.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, August 1, 2017
Antimicrobial agents and chemotherapy, July 25, 2017
PloS one, November 11, 2016
Antimicrobial agents and chemotherapy, October 21, 2016
PLoS neglected tropical diseases, August 10, 2016
BMC infectious diseases, February 1, 2016
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, June 30, 2015
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, April 11, 2014
Emerging infectious diseases, March 1, 2011